Psychological, social and biological determinants of ill health (pSoBid): Study Protocol of a population-based study

详细信息    查看全文

• 作者：Yoga N Velupillai (1)
  Chris J Packard (2)
  G David Batty (3)
  Vladimir Bezlyak (4)
  Harry Burns (5)
  Jonathan Cavanagh (6)
  Kevin Deans (7)
  Ian Ford (4)
  Agnes McGinty (8)
  Keith Millar (6)
  Naveed Sattar (9)
  Paul Shiels (10)
  Carol Tannahill (1)
  
• 刊名：BMC Public Health
• 出版年：2008
• 出版时间：December 2008
• 年：2008
• 卷：8
• 期：1
• 全文大小：872KB
• 参考文献：1. Davey Smith G: Socioeconomic differentials. / A life course approach to chronic disease epidemiology Oxford: Oxford University Press 1997.
  2. Ionescu MV, Carey F, Tait IS, Steele RJ: Socioeconomic status and stage at presentation of colorectal cancer [letter] [see comments]. / Lancet 1998, 352: 1439. CrossRef
  3. Tunstall-Pedoe H, Woodward M, Tavendale R, Brook RA, McCluskey MK: Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. / BMJ 1997, 315: 722-29.
  4. Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975áand 1994. / Heart 1999, 81: 380-86.
  5. Shewry MC, Smith WC, Woodward M, Tunstall-Pedoe H: Variation in coronary risk factors by social status: results from the Scottish Heart Health Study. / Br J Gen Pract 1992, 42: 406-10.
  6. Solar O, Irwin A, Vega J: / A conceptual Framework for Action on the Social Determinants of Health Geneva 2007.
  7. Hanlon P, Walsh D, Whyte BW: / Let Glasgow Flourish Glasgow Centre for Population Health 2006.
  8. Marmot M: / In sickness and in wealth: social causes of illness 1995.
  9. Marmot M, Wilkinson RG: / Social determinants of health New York: Oxford University Press Inc 1999.
  10. O'Reilly DS, Upton MN, Caslake MJ, Robertson M, Norrie J, McConnachie A, Watt GCM, Packard CJ, on behalf of the Midspan and WOSCOPS study groups: Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation. / Heart 2006, 92: 533-35. CrossRef
  11. Sattar N, McConnachie A, O'Reilly D, Upton MN, Greer IA, Smith G, Watt G: Inverse Association Between Birth Weight and C-Reactive Protein Concentrations in the MIDSPAN Family Study. / Arterioscler Thromb Vasc Biol 2004, 24: 583-87. CrossRef
  12. Gimeno D, Brunner EJ, Lowe GD, Rumley A, Marmot MG, Ferrie JE: Adult socioeconomic position, C-reactive protein and interlukin-6 in the Whitehall II prospective study. / European Journal of Epidemiology 2007, 22: 675-83. CrossRef
  13. Ross R: Atherosclerosis -An Inflammatory Disease. / N Engl J Med 1999, 340: 115-26. CrossRef
  14. Libby P, Theroux P: Pathophysiology of coronary artery disease. / Circulation 2005, 111: 3481-488. CrossRef
  15. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GDO, O'Reilly D, Packard CJ, Sattar N: C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study. / Diabetes 2002, 51: 1596-600. CrossRef
  16. Stern MP: Diabetes and cardiovascular disease. The "common soil" hypothesis. / Diabetes 1995, 44: 369-74. CrossRef
  17. Sattar N, McCarey DW, Capell H, McInnes IB: Explaining How "High-Grade" Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis. / Circulation 2003, 108: 2957-963. CrossRef
  18. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE: Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging. / Neurology 2002, 59: 371-78.
  19. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T: Inflammatory markers and cognition in well-functioning African-American and white elders. / Neurology 2003, 61: 76-0.
  20. Wright CE, Strike PC, Brydon L, Steptoe A: Acute inflammation and negative mood: Mediation by cytokine activation. / Brain, Behavior, and Immunity 2005, 19: 345-50. CrossRef
  21. Schram MT, Euser SM, de Craen AJM, Witteman JCM, Frolich M, Hofman A, Jolles J, Breteler MMB, Westendorp RGJ: Systemic markers of inflammation and cognitive decline in old age. / J Am Geriatr Soc 2007, 55: 708-16. CrossRef
  22. Stern MP: Diabetes and cardiovascular disease. The "common soil" hypothesis. / Diabetes 1995, 44: 369-74. CrossRef
  23. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B: Recent advances in the relationship between obesity, inflammation and insulin resistance. / Eur Cytokine Netw 2006, 17: 4-2.
  24. Hotamisligil GS: Inflammation and metabolic disorders. / Nature 2006, 444: 860-67. CrossRef
  25. Wild SH, Byrne CD: Risk factors for diabetes and coronary heart disease. / BMJ 2006, 333: 1009-011. CrossRef
  26. Stunkard AJ, Faith MS, Allison KC: Depression and obesity. / Biological Psychiatry 2003, 54: 330-37. CrossRef
  27. Katon WJ: Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. / Biological Psychiatry 2003, 54: 216-26. CrossRef
  28. Messier C: Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. / Neurobiology of Aging 2005, 26: 26-0. CrossRef
  29. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M: The Association Between C-Reactive Protein Levels and Depression: Results from the Northern Finland 1966 Birth Cohort Study. / Biological Psychiatry 2006, 60: 825-30. CrossRef
  30. Teunissen CE, Boxtel MP, Bosma H, Jolles J, Lutjohann D, Bergmann K, Wauters A, Bosmans E, Maes M, Delanghe J, De Bruijn C, Steinbusch HW, Blom HJ, de Vente J: Serum markers in relation to cognitive functioning in an aging population: results of the Maastricht Aging Study (MAAS). / Tijdschr Gerontol Geriatr 2003, 34: 6-2.
  31. Hemingway H, Shipley M, Mullen MJ, Kumari M, Brunner E, Taylor M, Donald AE, Deanfield JE, Marmot M: Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). / The American Journal of Cardiology 2003, 92: 984-87. CrossRef
  32. Lawlor DA, Smith GD, Ebrahim S: Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study. / BMJ 2003, 327: 1383-384. CrossRef
  33. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis. / Psychosom Med 2004, 66: 802-13. CrossRef
  34. Melle JP, de Jonge P, Spijkerman TA, Tijssen JGP, Ormel J, van Veldhuisen DJ, Brink RHS, Berg MP: Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis. / Psychosom Med 2004, 66: 814-22. CrossRef
  35. Denollet J, Brutsaert DL: Reducing Emotional Distress Improves Prognosis in Coronary Heart Disease: 9-Year Mortality in a Clinical Trial of Rehabilitation. / Circulation 2001, 104: 2018-023. CrossRef
  36. Glasgow Centre for Population Health [http://www.gcph.co.uk]
  37. General Practice Administration System for Scotland (GPASS) [http://www.gpass.scot.nhs.uk/]
  38. Community Health Index [http://www.chiadvisorygroup.scot.nhs.uk/]
  39. Scottish Index for Multiple deprivation [http://www.scotland.gov.uk/Topics/Statistics/SIMD/Overview]
  40. Patient Information Booklet [http://www.gcph.co.uk/index.php?option=com_docman&task=doc_download&gid=236]
  41. Goldberg DP: / The detection of psychiatric illness by questionnaire London: Oxford University Press 1972.
  42. Singh-Manoux A, Ferrie JE, Lynch JW, Marmot M: The Role of Cognitive Ability (Intelligence) in Explaining the Association between Socioeconomic Position and Health: Evidence from the Whitehall II Prospective Cohort Study. / Am J Epidemiol 2005, 161: 831-39. CrossRef
  43. Johnston M, Wright SJ, Weinman J: / Generalised self-efficacy scale. Measures in health psychology: a user's portfolio Windsor: NFER-Nelson 1995.
  44. Antonovsky A: The structure and properties of the sense of coherence scale. / Soc Sci Med 1993, 36: 725-33. CrossRef
  45. Beck TA, Steer RA: / Beck Hopelessness Scale London: Harcourt Assessment 2007.
  46. Smith AP, Clark R, Gallagher J: Breakfast Cereal and Caffeinated Coffee: Effects on Working Memory, Attention, Mood, and Cardiovascular Function. / Physiology & Behavior 1999, 67: 9-7. CrossRef
  47. Smith AP, Kendrick AM: Meals and performance. / Handbook of human performance San Diego: Academic Press 1992., 2:
  48. Eysenck HJ, Eysenck SBG: / EPQ-R short scale. London 1991.
  49. Johnston M, Wright SJ, Weinman J: / Rosenberg self-esteem scale. Measures in health psychology: a user's portfolio Windsor: NFER-Nelson 1995.
  50. Reitan RM, Wolfson D: Category test and trail making test as measures of frontal lobe functions. / The Clinical Neuropsychologist 1995, 9: 50-6. CrossRef
  51. Trenerry MR, Crosson B, DeBoe J, Leber WR: / Stroop Neuropsychological Screening Test Odessa, Florida: Psychological assessment Resources 1989.
  52. Crawford JR, Deary IJ, Starr JM, Whalley LJ: The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. / Psychological Medicine 2001, 31: 451-58. CrossRef
  53. Deary IJ, Der G, Ford G: Reaction times and intelligence differences: A population-based cohort study. / Intelligence 2001, 29: 389-99. CrossRef
  54. de Groot E, Zwindeerman AH, Steen AFW, Ackerstaff RGA, Swijndregt ADM, Bom N, Lie KI, Bruschke AVG: Varience Components Analysis of Cartoid and Femoral Intima-Media Thickness Measurements. / Ultrasound in Medicine and Biology 1998, 24: 825-32. CrossRef
  55. John JP, Kastelein MDP, Erik SG, Stroes MDP, Eric de Groot MDP: Subclinical atherosclerosis as a target of therapy: potential role of statins. / The American Journal of Cardiology 2004, 93: 737-40. CrossRef
  56. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J: Chronic Infections and the Risk of Carotid Atherosclerosis : Prospective Results From a Large Population Study. / Circulation 2001, 103: 1064-070.
  57. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S: Relationship of Periodontal Disease to Carotid Artery Intima-Media Wall Thickness: The Atherosclerosis Risk in Communities (ARIC) Study. / Arterioscler Thromb Vasc Biol 2001, 21: 1816-822. CrossRef
  58. Meer IM, Bots ML, Hofman A, Iglesias A, Kuip DAM, Witteman JCM: Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction: The Rotterdam Study. / Circulation 2004, 109: 1089-094. CrossRef
  59. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieu M, Ebrahim S, Fatar M, Hernandez RH, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F: Mannheim Intima-Media Thickness Consensus. / Cerebrovascular Diseases 2004, 18: 346-49. CrossRef
  60. Hollander M, Bots ML, del Sol AI, Koudstaal PJ, Witteman JCM, Grobbee DE, Hofman A, Breteler MMB: Carotid Plaques Increase the Risk of Stroke and Subtypes of Cerebral Infarction in Asymptomatic Elderly: The Rotterdam Study. / Circulation 2002, 105: 2872-877. CrossRef
  61. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction : The Rotterdam Study 1192. / Circulation 1997, 96: 1432-437.
  62. Lawlor DA, Ebrahim S, Whincup P, Sterne J, Papacosta O, Wannamethee G, Dhanjil S, Griffin M, Nicolaides AN, Davey Smith G: Sex differences in body fat distribution and carotid intima media thickness: cross sectional survey using data from the British regional heart study. / J Epidemiol Community Health 2004, 58: 700-04. CrossRef
  63. Carstairs V, Morris R: / Deprivation and Health in Scotland Aberdeen: Aberdeen University Press 1991.
  64. Bishop J, Clark D, Harris V, Stockton D, Sutton M: / Deprivation and Urban Rural Measurement in ISD Edinburgh 2004.
  65. / The Scottish Health Survey 2003 Edinburgh 2005.
  66. pSoBid study website within GCPH website [http://www.gcph.co.uk/index.php?option=com_content&task=view&id=28&Itemid=44]
  67. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/8/126/prepub
  
• 作者单位：Yoga N Velupillai (1)
  Chris J Packard (2)
  G David Batty (3)
  Vladimir Bezlyak (4)
  Harry Burns (5)
  Jonathan Cavanagh (6)
  Kevin Deans (7)
  Ian Ford (4)
  Agnes McGinty (8)
  Keith Millar (6)
  Naveed Sattar (9)
  Paul Shiels (10)
  Carol Tannahill (1)
  
  1. Glasgow Centre for Population Health, Level 6, 39 St Vincent Place, Glasgow, G1 2ER, UK
  2. Dept. Vascular Biochemistry, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, 4th Floor University Block, 10 Alexandra Parade, Glasgow, G31 2ER, UK
  3. MRC Social and Public Health Sciences Unit, 4 Lilybank Gardens, Glasgow, G12 8RZ, UK
  4. Robertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, University Avenue, Glasgow, G12 8QQ, UK
  5. Scottish Executive, St. Andrew's House, Regent Road, Edinburgh, EH1 3DG, UK
  6. Section of Psychological Medicine, Faculty of Medicine, University of Glasgow, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, G12 0XH, UK
  7. Dept. of Clinical Biochemistry, Macewen Building, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK
  8. Rosehill, Munros Street, Alexandria, Dunbartonshire, G83 0PU6, UK
  9. Division of Cardiovascular and Medical Sciences based at Vascular Biochemistry, Glasgow Royal Infirmary, University of Glasgow, 4th Floor QEB, 10 Alexandra Parade, Glasgow, G31 2ER, UK
  10. Faculty of Medicine, University Dept. Surgery, Level 2, Q.E.B, Glasgow Royal Infirmary, University of Glasgow, 10 Alexandra Parade, G31 2ER, UK
  
• ISSN：1471-2458

文摘

Background Disadvantaged communities suffer higher levels of physical and mental ill health than more advantaged communities. The purpose of the present study was to examine the psychosocial, behavioural and biological determinants of ill health within population groups in Glasgow that differed in socioeconomic status and in their propensity to develop chronic disease especially coronary heart disease and Type 2 diabetes mellitus. Methods Participants were selected at random from areas known to be at the extremes of the socioeconomic continuum in Glasgow. Within the categories of least deprived and most deprived, recruitment was stratified by sex and age to achieve an overall sample containing approximately equal numbers of males and females and an even distribution across the age categories 35-4, 45-4 and 55-4 years. Individuals were invited by letter to attend for assessment of their medical history, risk factor status, cognitive function and psychological profile, morbidity, and carotid intima-media thickness and plaque count as indices of atherosclerosis. Anonymised data on study subjects were collected from the General Practice Administration System for Scotland to analyse characteristics of participants and non-participants. Results 700 subjects were recruited. The response (active participants per 100 invitation letters) in the least deprived group was 35.1% and in the most deprived group was 20.3%. Lowest response was seen in young males (least deprived 22.4% and most deprived 14.1%). Conclusion This cross-sectional study recruited the planned sample of subjects from least deprived and most deprived areas within Glasgow. As evident in other studies response differed between the most and least deprived areas. This study brought together researchers/academics from diverse disciplines to build a more sophisticated understanding of the determinants of health inequalities than can be achieved through unidisciplinary approaches. Future analyses will enable an understanding of the relationships between the different types of measure, and of the pathways that link poverty, biology, behaviour and psychology and lead to health inequalities.